Document Detail

Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.
MedLine Citation:
PMID:  22284249     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: The growth differentiation factor 15 (GDF-15) has been shown up-regulated in stress conditions and to have regulatory actions in myocyte hypertrophy. We hypothesized that GDF-15 could be related to disease severity and functional status in patients with hypertrophic cardiomyopathy (HCM).
METHODS AND RESULTS: We performed a study which includes 102 consecutive outpatient HCM subjects, 73% males, aged 47.1±14.6years. A complete history and clinical examination was performed, including 12-lead electrocardiogram, echocardiography, symptom-limited treadmill exercise, 24-hour ECG-Holter monitoring, and magnetic resonance with Gadolinium. Several biomarkers, associated with myocardial remodeling and damage, were compared to GDF-15 levels. The assays were performed with commercial ELISAs or standardized methods when available. There was a significant association between GDF-15 levels and comorbidities, being higher in hypertension (p=0.001), diabetes (p=0.030), atrial fibrillation (p=0.012), dyspnea (p=0.020) and NYHA≥II functional class (p=0.037). GDF-15 levels were positively correlated with clinical variables (age, worse exercise capacity and mild renal dysfunction) and biomarkers of interstitial remodeling, such as metalloproteinase-2 (r: 0.40; p=0.009), N-terminal pro-B-type natriuretic peptide (r: 0.28; p=0.049), high-sensitivity troponin T (r: 0.30; p=0.003) and von Willebrand factor (r: 0.33; p=0.001). Multivariate analysis was assessed to estimate the involvement of these different factors in the GDF-15 levels, confirming the independent implication of severe dyspnea and functional status.
CONCLUSIONS: The present results show that higher levels of GDF-15 are associated to conditions of severe disease in HCM. Hence, GDF-15 is suggested as a novel marker related to the severity and could represent a further useful tool in monitoring functional capacity of HCM patients.
Silvia Montoro-García; Diana Hernández-Romero; Eva Jover; Antonio García-Honrubia; Juan A Vilchez; Teresa Casas; Pedro Martínez; Vicente Climent; Luis Caballero; Mariano Valdés; Francisco Marín
Related Documents :
24657739 - Moderate treadmill exercise rescues anxiety and depression-like behavior as well as mem...
20420759 - Postprandial lipaemia does not affect resting haemodynamic responses but does influence...
8164539 - Unilateral carotid-cardiac baroreflex responses in exercise trained and untrained men.
23737159 - A hypothetical protocol for the provisional use of perfusion imaging with exercise stre...
6941599 - Measurement of central hemodynamic parameters during preoperative exercise testing in p...
3804909 - Effect of methylene blue on cardiac output response to exercise in dogs.
12381089 - Left atrial function preserves pulmonary circulatory pressure during pacing-tachycardia...
20336309 - Application of bioreactance for cardiac output assessment during exercise in healthy in...
23569199 - Role of exercise in the prevention of cardiovascular disease: results, mechanisms, and ...
Publication Detail:
Type:  Journal Article     Date:  2011-09-15
Journal Detail:
Title:  European journal of internal medicine     Volume:  23     ISSN:  1879-0828     ISO Abbreviation:  Eur. J. Intern. Med.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-01-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9003220     Medline TA:  Eur J Intern Med     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  169-74     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, University of Murcia, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication o...
Next Document:  Association between the polymorphism of estrogen receptor ? and coronary artery disease in a Chinese...